In contrast, the data of Te′llez-Gabriel et al. [14] supported a tumor suppressor role for Rab25 in head and neck squamous cell carcinoma and its potential use to identify locally advanced patients with a high probability of survival after genotoxic treatment; Goldenring et al. [16] reported that colorectal adenocarcinomas with low Rab25 correlated with shorter patient survival. This evidence concerns the gene RAB25 and colorectal adenocarcinoma.